Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-08

Clinical Trial Update: Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update reporting on the molecular effects of vitamin B3 (niacinamide) in acute kidney injury during early-phase research; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niacinamide (nicotinamide)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Acute Kidney Injury | EARLY_Phase 1 | Status: COMPLETED